Amgen Inc
About
Amgen is a global biotechnology company that discovers, develops, manufactures and delivers innovative medicines for serious illnesses, typically diseases with a limited number of treatment options. A biotechnology pioneer since 1980, it is known for the science of using living cells to make biologic medicines and has reached millions of patients around the world. Its Cambridge presence is listed with the Kendall Square Association, and the company is developing a pipeline of new medicines.
Headquartered in Thousand Oaks, California, Amgen shares patient and science stories on conditions such as thyroid eye disease, discoid lupus erythematosus, Sjogren’s disease and IgG4-related disease, along with early-onset colorectal cancer. It is also exploring how artificial intelligence can speed drug discovery, and its Ecovation program builds sustainability into its operations. Bob Bradway is chief executive, and the company backs efforts ranging from pediatric cancer research with Stand Up To Cancer and MrBeast to the Amgen Irish Open golf tournament.
What to Know
- Forbes ranked Amgen fourth on its list of the most innovative large companies.
- It was named to The Wall Street Journal’s inaugural Best Companies for the Future list in 2026.
- U.S. Veterans Magazine included Amgen among its 2026 top veteran employers.
- Amgen is also listed with the Cambridge and Greater Boston chambers of commerce.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.